Cyclic Nucleotide Phosphodiesterases, Type 2 [cyklické nukleotidfosfodiesterasy, typ 2]
- Terms
-
cyklické nukleotidfosfodiesterasy, typ 2A
cyklické nukleotidfosfodiesterázy, typ 2
cyklické nukleotidfosfodiesterázy, typ 2A
-
cGMP-Dependent 3',5'-Cyclic Phosphodiesterase
Cyclic GMP-Stimulated Phosphodiesterase
Cyclic Nucleotide Phosphodiesterase PDE2 Family
Cyclic Nucleotide Phosphodiesterases, Type 2A
PDE2 Phosphodiesterase
PDE2 Phosphodiesterases
Phosphodiesterase 2A
A cyclic nucleotide phosphodiesterase subfamily that is activated by the binding of CYCLIC GMP to an allosteric domain found on the enzyme. Multiple enzyme variants of this subtype can be produced due to multiple alternative mRNA splicing. The subfamily is expressed in a broad variety of tissues and may play a role in mediating cross-talk between CYCLIC GMP and CYCLIC CMP pathways. Although the type 2 enzymes are classified as 3',5'-cyclic-AMP phosphodiesterases (EC 3.1.4.17), members of this class have additional specificity for CYCLIC GMP.
- DUI
- D054678 MeSH Browser
- CUI
- M0368692
- History note
- 2008(2000)
- Public note
- 2008; PDE2 PHOSPHODIESTERASE now CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 2 was indexed under PHOSPHORIC DIESTER HYDROLASES 2000-2007
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0